White Pine Capital LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 280.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,135 shares of the healthcare conglomerate’s stock after acquiring an additional 3,049 shares during the quarter. White Pine Capital LLC’s holdings in UnitedHealth Group were worth $1,428,000 as of its most recent SEC filing.
Other institutional investors also recently modified their holdings of the company. Jackson Grant Investment Advisers Inc. grew its holdings in shares of UnitedHealth Group by 68.9% during the third quarter. Jackson Grant Investment Advisers Inc. now owns 2,467 shares of the healthcare conglomerate’s stock worth $852,000 after buying an additional 1,006 shares in the last quarter. ROSS JOHNSON & Associates LLC grew its stake in shares of UnitedHealth Group by 1,461.5% during the 3rd quarter. ROSS JOHNSON & Associates LLC now owns 203 shares of the healthcare conglomerate’s stock worth $70,000 after acquiring an additional 190 shares in the last quarter. Personal CFO Solutions LLC lifted its position in shares of UnitedHealth Group by 30.8% in the third quarter. Personal CFO Solutions LLC now owns 5,399 shares of the healthcare conglomerate’s stock worth $1,864,000 after purchasing an additional 1,270 shares in the last quarter. DC Investments Management LLC bought a new position in UnitedHealth Group in the third quarter valued at $5,764,000. Finally, Tredje AP fonden lifted its position in UnitedHealth Group by 31.7% during the 3rd quarter. Tredje AP fonden now owns 459,417 shares of the healthcare conglomerate’s stock worth $158,637,000 after buying an additional 110,583 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
UNH has been the topic of several analyst reports. Wells Fargo & Company dropped their target price on UnitedHealth Group from $400.00 to $370.00 and set an “overweight” rating on the stock in a report on Friday, January 30th. Barclays dropped their price objective on UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating on the stock in a research note on Friday, January 30th. Royal Bank Of Canada lowered their target price on shares of UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating on the stock in a report on Wednesday, January 28th. Truist Financial decreased their price objective on shares of UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating for the company in a research report on Monday, February 2nd. Finally, Deutsche Bank Aktiengesellschaft cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price target for the company. in a report on Wednesday, October 29th. One research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $372.13.
UnitedHealth Group Stock Performance
NYSE UNH opened at $290.11 on Friday. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $606.36. The stock has a market cap of $262.79 billion, a PE ratio of 21.99, a PEG ratio of 1.33 and a beta of 0.41. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.82 and a current ratio of 0.79. The firm’s fifty day moving average price is $316.85 and its two-hundred day moving average price is $324.23.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, topping analysts’ consensus estimates of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business had revenue of $113.22 billion for the quarter, compared to analyst estimates of $113.38 billion. During the same quarter in the previous year, the company posted $6.81 EPS. UnitedHealth Group’s quarterly revenue was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Profile
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
